According to American Thyroid Association (ATA) guideline, papillary thyroid cancer (PTC) with minimal extrathyroidal extension (mETE) is classified at "intermediate risk" of persistent/recurrent disease. However, the impact of mETE per se on patients' outcome is not fully understood. The aim of our study was to evaluate the prognostic significance of mETE in patients with PTC not submitted to therapeutic or prophylactic lymph node dissection, according to tumor size and other prognostic factors.
Castagna, M.G., Forleo, R., Maino, F., Fralassi, N., Barbato, F., Palmitesta, P., et al. (2018). Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 41, 1029-1035 [10.1007/s40618-018-0854-8].
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor
Castagna, M G;FORLEO, RAFFAELLA;Palmitesta, P;Cantara, S;Formichi, C;Pacini, F
2018-01-01
Abstract
According to American Thyroid Association (ATA) guideline, papillary thyroid cancer (PTC) with minimal extrathyroidal extension (mETE) is classified at "intermediate risk" of persistent/recurrent disease. However, the impact of mETE per se on patients' outcome is not fully understood. The aim of our study was to evaluate the prognostic significance of mETE in patients with PTC not submitted to therapeutic or prophylactic lymph node dissection, according to tumor size and other prognostic factors.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Castagna2018_Article_SmallPapillaryThyroidCarcinoma.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
810.08 kB
Formato
Adobe PDF
|
810.08 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1046993